SCHEMBL32688293

SCHEMBL32688293

CCOC(=O)CC(=O)c1cccc(N2CCN(C)CC2)c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLOD2 O00469 3/20 0.65
PLOD3 O60568 3/20 0.65
PLOD1 Q02809 3/20 0.65
HDAC3 O15379 6/20 0.51
HDAC8 Q9BY41 6/20 0.51
HDAC4 P56524 4/20 0.51
HDAC1 Q13547 4/20 0.51
HDAC7 Q8WUI4 4/20 0.51
HDAC2 Q92769 4/20 0.51
HDAC10 Q969S8 4/20 0.51
HDAC11 Q96DB2 4/20 0.51
HDAC6 Q9UBN7 4/20 0.51
HDAC9 Q9UKV0 4/20 0.51
HDAC5 Q9UQL6 4/20 0.51
HTR2C P28335 1/20 0.46
HTR1D P28221 1/20 0.45
HTR1B P28222 1/20 0.45
HTR2A P28223 1/20 0.45
ADRA2C P18825 1/20 0.44
ALDH1A1 P00352 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32688239 0.91 PLOD2 (0.53) PLOD2PLOD3PLOD1ALDH1A1MAPT
SCHEMBL32688378 0.90 ALDH1A1 (0.55) PLOD2PLOD3PLOD1ALDH1A1MAPT
SCHEMBL32688300 0.89 ALDH1A1 (0.54) PLOD2PLOD3PLOD1ALDH1A1MAPT
SCHEMBL32688024 0.88 PLOD2 (0.50) PLOD2PLOD3PLOD1ALDH1A1MAPT
SCHEMBL8698788 0.84 PLOD2 (0.56) PLOD2PLOD3PLOD1HDAC3HDAC8
SCHEMBL3651005 0.84 HDAC3 (0.59) HDAC3HDAC8ALDH1A1MAPTLMNA
SCHEMBL32688003 0.83 GPR119 (0.52) PLOD2PLOD3PLOD1ALDH1A1MAPT
SCHEMBL17420453 0.80 AGXT (0.56) PLOD2PLOD3PLOD1HTR2CHTR1B
SCHEMBL3656425 0.79 GAA (0.60) ALDH1A1MAPTMAPK1LMNAMEN1
SCHEMBL10739904 0.79 PLOD2 (0.66) PLOD2PLOD3PLOD1HDAC3HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors ORSOBIO INC (US) 2026-03-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors CPT1B, CBR1, MUSK PLOD2 1971/4885PLOD3 1667/4885PLOD1 1540/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.